ZVRA
ZVRA
US4884452065
Zevra Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
676.38M EUR
850.96M EUR
550.95M EUR
509.42M EUR
Enterprise Value
433.15M EUR
707.14M EUR
456.5M EUR
510.22M EUR
Valuation Multiples
Trailing P/E
12.38x
14.61x
4.44x
5.9x
Forward P/E
10.58x
--
--
--
Price to Sales
4.97x
6.25x
4.51x
5.92x
Price to Book
3.11x
3.91x
2.68x
3.29x
EV/Revenue
3.18x
5.2x
3.73x
5.93x
EV/EBITDA
10.68x
13.94x
20.09x
51.35x
Price to FCF (P/FCF)
13.98x
26.08x
45.93x
86.52x
EV/FCF
8.95x
21.68x
38.06x
86.65x
FCF Yield
7.15%
3.83%
2.18%
1.16%
ende